Healthtech Startups

Coordinista provides technology solutions designed to improve engagement and care outcomes for high-acuity and hard-to-reach patient populations through clinician-friendly tools that support care teams in delivering meaningful care services.

2 investors

Corcym is a medical device company that develops therapies and devices for patient care. The page emphasizes product safety information and customer support for medical device users.

2 investors

Cordata provides a coordination platform that helps communities organize long-term support across healthcare, human services, and public systems, enabling active connection of individuals to services rather than simple referrals.

2 investors

CORE Biomedicine is a biotech company developing precision cancer medicines based on cancer lineage biology, focused on advancing drug candidates from discovery into clinical development.

2 investors

Core Dermatology is a dermatology practice providing personalized skincare treatments, including dermatological and plastic surgery services, delivered by board-certified specialists.

2 investors

Cori Clinical builds an AI platform that automates the authoring and management of clinical trial documentation, including protocols, consent forms, and regulatory submissions. The platform serves clinical development teams by reducing manual document preparation and ensuring consistency across all trial-related paperwork.

2 investors

Coridea invests in and develops healthcare companies focused on patient-centric solutions. The firm provides capital and support to high-impact medical technology and healthcare ventures.

2 investors

Corporis Medical develops medical devices for surgical and diagnostic applications, focusing on innovations like perfusion measurement systems and clinical validation.

2 investors

CorrectSequence Therapeutics develops base-editing gene therapies using its proprietary transformer Base Editor (tBE) platform to treat genetic diseases, rare diseases, and common conditions including inherited disorders, metabolic diseases, cardiovascular diseases, and cancers. The company has advanced multiple pipeline candidates into clinical and investigational stages, including programs for β-thalassemia and sickle cell disease.

2 investors

CortiCare provides remote continuous EEG monitoring as a virtual EEG department that supports hospital clinical teams rather than replacing them. Its quality assurance program sets standards for technologists, monitoring workflows, and clinical escalation to maintain consistent EEG monitoring across hospitals in the US.

2 investors

Cortrium develops a long-term ECG solution that combines wearable hardware, algorithms, and human expertise for recording and reporting to identify arrhythmias and prevent heart disease and stroke. It serves cardiology and healthcare professionals and their patients, operating across multiple countries through partners and distributors.

2 investors

Corvion develops fully implantable left ventricular assist devices (LVADs) for cardiac patients. The company focuses on improving the quality of life and survival outcomes for patients with advanced heart failure.

2 investors

Cosan Group provides virtual care management infrastructure and intelligent automation services that extend clinical care beyond office visits for healthcare providers. The platform helps practices manage patient care remotely, improve health outcomes, and reduce costs while emphasizing compassionate, evidence-based care.

2 investors

Cosm develops advanced pessary devices for conservative (non-surgical) treatment of pelvic floor disorders including prolapse and incontinence in women. The company focuses on addressing an underserved market through the Gynethotics product line.

2 investors

Cosomil develops single-molecule enzyme activity measurement technology for early disease diagnosis and drug development support in healthcare. The company serves medical research institutions, pharmaceutical manufacturers, and diagnostic laboratories in Japan.

2 investors

Cotera provides a platform for building and deploying AI agents that automate internal operations, customer support, and complex multi-agent systems for companies of all sizes. The platform enables companies to integrate, oversee, and manage AI workflows to improve operational efficiency.

2 investors

Coterie provides products and services designed to support parents during their child's early years, offering solutions to simplify parenting tasks and improve family life.

2 investors

Cotton Mouton Diagnostics operates a UKAS-accredited laboratory offering endotoxin testing services for liquid pharmaceutical products, including method development, validation, and low endotoxin recovery studies. It also produces the αBET System, an in-house testing platform combining FUJIFILM Wako's licensed LAL reagent with its own magneto-optical technology for pharmaceutical and diagnostics customers.

2 investors

Cottonball delivers custom-compounded prescription skincare formulas prescribed by dermatologists based on individual skin profiles, shipped directly to customers. The service combines telemedicine consultation with pharmacy compounding to create personalized skincare treatments at specified ingredient concentrations.

2 investors

Cove builds brain data analytics tools that combine data engineering and neuroscience to support patient care. The company is developed by a team of physicians, neuroscientists, and software engineers.

2 investors

CREAL develops light-field display technology for augmented and mixed reality, enabling full 3D visualization in XR devices such as smart glasses. Its engineering work spans optics and electronics for next-generation display and XR hardware.

2 investors

CREATE Medicines is a clinical-stage biotech company that develops in vivo mRNA immune cell programming therapies. The company focuses on RNA therapeutics and immune engineering for cancer, autoimmune disease, and transplant rejection applications.

2 investors

Lang Lai Technology (朗来科技) is a clinical-stage drug discovery company that runs an end-to-end new-drug R&D process spanning proof of concept, candidate compound screening, preclinical druggability development, and clinical research, pursuing both pipeline development and platform building. It operates R&D, translational medicine, and clinical centers across China and a business-development/FDA-filing center in the United States.

2 investors

Creature Comforts operates member-based veterinary clinics in the UK designed to improve pet health outcomes and vet wellbeing through relationship-focused care. The company offers affordable monthly memberships with unlimited consultations, transparent pricing, and app-enabled virtual support, alongside calming clinic environments and community programs.

2 investors